Product Information

ZAFIRLUKAST 10 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.5416 per EA under NDC 31722000760. Its NADAC has been published 309 times since Dec 16, 2020.

FDA first approved this application on Sep 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZAFIRLUKAST 10 MG TABLET

Zafirlukast
$0.5416per EA

Strength

10 mg/1

NDC

31722000760

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ZAFIRLUKAST

Approval Type

Generic (ANDA)

FDA Application

ANDA212475

FDA Approved

9/10/2020

TE Code

AB

On Market Since

9/10/2020

Pharmacological Classes

Cytochrome P450 2C9 Inhibitors
Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for ZAFIRLUKAST 10 MG TABLET has been published 309 times since Dec 16, 2020, and over the history we have for it it has declined 44.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5416 per EA
All-time high$1.0831 (Apr 13, 2022)
All-time low$0.4056 (Feb 19, 2025)
52-week high$0.5815
52-week low$0.5023
Median price$0.7430
Average price$0.7398
Largest weekly change+24.7% (Dec 20, 2023)
Weeks tracked309
Tracking sinceDec 16, 2020

Price History

1W

0.0%

1M

+4.8%

3M

+0.6%

6M

+7.8%

1Y

-6.9%

3Y

-27.1%

5Y

-36.3%

All

-44.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZAFIRLUKAST 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 10 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.5416 per EA (NDC 31722000760), effective Nov 11, 2026.

How has the price of ZAFIRLUKAST 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZAFIRLUKAST 10 MG TABLET has declined 44.6%. It has been tracked across 309 weekly CMS publications since Dec 16, 2020.

What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 10 MG TABLET?

Since Dec 16, 2020, the NADAC for ZAFIRLUKAST 10 MG TABLET has ranged from a low of $0.4056 (Feb 19, 2025) to a high of $1.0831 (Apr 13, 2022), with a median of $0.7430 per EA.

Are there cheaper alternatives to ZAFIRLUKAST 10 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZAFIRLUKAST 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZAFIRLUKAST 10 MG TABLET?

ZAFIRLUKAST 10 MG TABLET (NDC 31722000760) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.